Literature DB >> 23622731

Primary fallopian tube carcinoma.

E Kalampokas1, T Kalampokas, I Tourountous.   

Abstract

Primary fallopian tube carcinoma (PFTC) is a rare gynaecological tumour that accounts for 0.14-1.8% of genital malignancies. The most common age of occurrence is between 40 and 65 years, and the mean age is 55 years. The factors that contribute to its appearance are not well known. Population studies show that the mean incidence of PFTC is 3.6 per million women per annum. Overall survival percentages for patients with PFTC are generally low, in the range of 22-57%. Pre-operative diagnosis is rare and PFTC is usually confirmed by a pathologist, but earlier diagnosis with early clinical manifestation and prompt investigation improves the prognosis. Both PFTC and epithelial ovarian cancer (EOC) are treated with similar surgical and chemotherapy methods. Studies have shown that the prognosis for PFTC is worse than that for EOC or other primary gynaecological tumours. This article reviews and presents the current updates of this rare gynaecological malignancy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fallopian tube carcinoma; High-grade serous carcinoma; Incidence; Risk factors; Treatment

Mesh:

Year:  2013        PMID: 23622731     DOI: 10.1016/j.ejogrb.2013.03.023

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  13 in total

1.  Successful diagnosis of an occult fallopian tube carcinoma detected from the diaphragm metastasis.

Authors:  Takahide Toyoda; Hidemi Suzuki; Takahiro Nakajima; Takekazu Iwata; Ayumu Matsuoka; Kyoko Nishikimi; Yoko Yonemori; Makio Shozu; Yukio Nakatani; Ichiro Yoshino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-01-11

2.  Fallopian Tube Tumor Mimicking Primary Gastrointestinal Malignancy.

Authors:  Anupam K Gupta; Oscar A Vazquez
Journal:  Cureus       Date:  2020-08-17

3.  Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study.

Authors:  Kemal Gungorduk; Ibrahim E Ertas; Aykut Ozdemir; Emrah Akkaya; Elcin Telli; Salih Taskin; Mehmet Gokcu; Ahmet Baris Guzel; Tufan Oge; Levent Akman; Tayfun Toptas; Ulas Solmaz; Askın Dogan; Mustafa Cosan Terek; Muzaffer Sanci; Aydin Ozsaran; Tayyup Simsek; Mehmet Ali Vardar; Omer Tarik Yalcin; Sinan Ozalp; Yusuf Yildirim; Firat Ortac
Journal:  Cancer Res Treat       Date:  2014-11-17       Impact factor: 4.679

4.  Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Authors:  Lauren Patterson Cobb; Stephanie Gaillard; Yihong Wang; Ie-Ming Shih; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2015-05-12

5.  Primary carcinoma of the fallopian tubes: Analysis of sixteen patients.

Authors:  Meryem Eken; Osman Temizkan; Ecmel Işık Kaygusuz; Dilşad Herkiloğlu; Ebru Çöğendez; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

6.  Primary Fallopian Tube Carcinoma: A Case Report and Literature Review.

Authors:  Meral Rexhepi; Elizabeta Trajkovska; Hysni Ismaili; Florin Besimi; Nagip Rufati
Journal:  Open Access Maced J Med Sci       Date:  2017-05-20

7.  Prognostic factors of primary fallopian tube carcinoma.

Authors:  Emrah Akkaya; Muzaffer Sanci; Nur G Kulhan; Mehmet Kulhan; Umit Nayki; Cenk Nayki; Nahit Ata; Pasa Ulug
Journal:  Contemp Oncol (Pozn)       Date:  2018-04-09

8.  Primary fallopian tube carcinoma: review of MR imaging findings.

Authors:  Filipe Veloso Gomes; João Lopes Dias; Rita Lucas; Teresa Margarida Cunha
Journal:  Insights Imaging       Date:  2015-07-07

9.  Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma.

Authors:  Hilal Gurler; Virgilia Macias; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  Biomolecules       Date:  2015-12-03

10.  Responses of metastatic primary fallopian tube carcinoma to pembrolizumab and nab-paclitaxel: A case report.

Authors:  Jian Jiang; Zhi-Peng Chen; Hui-Ping Zhu; Yong-Qin Zhang; Xiao-Lan Qian; Min Zhang; Chen Ni; Yun Zuo
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.